EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Aeglea BioTherapeutics, Inc. of our report dated March 8, 2022 relating to the financial statements, which appears in Aeglea BioTherapeutics, Inc.’s Annual report on Form 10-K for the year ended December 31, 2021.

/s/PricewaterhouseCoopers LLP

Austin, Texas

March 8, 2022